The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Angina-Global Market Insights and Sales Trends 2024
Synopsis
Angina is a type of chest pain caused by reduced blood flow to the heart. Angina (an-JIE-nuh or AN-juh-nuh) is a symptom of coronary artery disease. Angina, which may also be called angina pectoris, is often described as squeezing, pressure, heaviness, tightness or pain in your chest
The global Angina market size is expected to reach US$ 14180 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Angina in various end use industries. The expanding demands from the Clinics, Hospitals and Other, are propelling Angina market. Beta Blockers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Calcium Antagonists segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Angina, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Angina market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Angina market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Angina sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Angina covered in this report include Amgen, Taxus Cardium Pharmaceuticals, LegoChem Biosciences, Lee’s Pharmaceutical, Milestone Pharmaceuticals, Juventas Therapeutics, ViroMed and Kuhnil Pharmaceutical, etc.
The global Angina market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
Taxus Cardium Pharmaceuticals
LegoChem Biosciences
Lee’s Pharmaceutical
Milestone Pharmaceuticals
Juventas Therapeutics
ViroMed
Kuhnil Pharmaceutical
Global Angina market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Angina market, Segment by Type:
Beta Blockers
Calcium Antagonists
Anticoagulants
Antiplatelet
Nitrates
ACE Inhibitors
Ranolazine
Global Angina market, by Application
Clinics
Hospitals
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Angina companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Angina is a type of chest pain caused by reduced blood flow to the heart. Angina (an-JIE-nuh or AN-juh-nuh) is a symptom of coronary artery disease. Angina, which may also be called angina pectoris, is often described as squeezing, pressure, heaviness, tightness or pain in your chest
The global Angina market size is expected to reach US$ 14180 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Angina in various end use industries. The expanding demands from the Clinics, Hospitals and Other, are propelling Angina market. Beta Blockers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Calcium Antagonists segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Angina, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Angina market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Angina market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Angina sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Angina covered in this report include Amgen, Taxus Cardium Pharmaceuticals, LegoChem Biosciences, Lee’s Pharmaceutical, Milestone Pharmaceuticals, Juventas Therapeutics, ViroMed and Kuhnil Pharmaceutical, etc.
The global Angina market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
Taxus Cardium Pharmaceuticals
LegoChem Biosciences
Lee’s Pharmaceutical
Milestone Pharmaceuticals
Juventas Therapeutics
ViroMed
Kuhnil Pharmaceutical
Global Angina market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Angina market, Segment by Type:
Beta Blockers
Calcium Antagonists
Anticoagulants
Antiplatelet
Nitrates
ACE Inhibitors
Ranolazine
Global Angina market, by Application
Clinics
Hospitals
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Angina companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Angina
1.1 Angina Market Overview
1.1.1 Angina Product Scope
1.1.2 Angina Market Status and Outlook
1.2 Global Angina Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Angina Market Size by Region (2018-2029)
1.4 Global Angina Historic Market Size by Region (2018-2023)
1.5 Global Angina Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Angina Market Size (2018-2029)
1.6.1 North America Angina Market Size (2018-2029)
1.6.2 Europe Angina Market Size (2018-2029)
1.6.3 Asia-Pacific Angina Market Size (2018-2029)
1.6.4 Latin America Angina Market Size (2018-2029)
1.6.5 Middle East & Africa Angina Market Size (2018-2029)
2 Angina Market by Type
2.1 Introduction
2.1.1 Beta Blockers
2.1.2 Calcium Antagonists
2.1.3 Anticoagulants
2.1.4 Antiplatelet
2.1.5 Nitrates
2.1.6 ACE Inhibitors
2.1.7 Ranolazine
2.2 Global Angina Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Angina Historic Market Size by Type (2018-2023)
2.2.2 Global Angina Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Angina Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Angina Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Angina Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Angina Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Angina Revenue Breakdown by Type (2018-2029)
3 Angina Market Overview by Application
3.1 Introduction
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Other
3.2 Global Angina Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Angina Historic Market Size by Application (2018-2023)
3.2.2 Global Angina Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Angina Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Angina Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Angina Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Angina Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Angina Revenue Breakdown by Application (2018-2029)
4 Angina Competition Analysis by Players
4.1 Global Angina Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angina as of 2022)
4.3 Date of Key Players Enter into Angina Market
4.4 Global Top Players Angina Headquarters and Area Served
4.5 Key Players Angina Product Solution and Service
4.6 Competitive Status
4.6.1 Angina Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen
5.1.1 Amgen Profile
5.1.2 Amgen Main Business
5.1.3 Amgen Angina Products, Services and Solutions
5.1.4 Amgen Angina Revenue (US$ Million) & (2018-2023)
5.1.5 Amgen Recent Developments
5.2 Taxus Cardium Pharmaceuticals
5.2.1 Taxus Cardium Pharmaceuticals Profile
5.2.2 Taxus Cardium Pharmaceuticals Main Business
5.2.3 Taxus Cardium Pharmaceuticals Angina Products, Services and Solutions
5.2.4 Taxus Cardium Pharmaceuticals Angina Revenue (US$ Million) & (2018-2023)
5.2.5 Taxus Cardium Pharmaceuticals Recent Developments
5.3 LegoChem Biosciences
5.3.1 LegoChem Biosciences Profile
5.3.2 LegoChem Biosciences Main Business
5.3.3 LegoChem Biosciences Angina Products, Services and Solutions
5.3.4 LegoChem Biosciences Angina Revenue (US$ Million) & (2018-2023)
5.3.5 Lee’s Pharmaceutical Recent Developments
5.4 Lee’s Pharmaceutical
5.4.1 Lee’s Pharmaceutical Profile
5.4.2 Lee’s Pharmaceutical Main Business
5.4.3 Lee’s Pharmaceutical Angina Products, Services and Solutions
5.4.4 Lee’s Pharmaceutical Angina Revenue (US$ Million) & (2018-2023)
5.4.5 Lee’s Pharmaceutical Recent Developments
5.5 Milestone Pharmaceuticals
5.5.1 Milestone Pharmaceuticals Profile
5.5.2 Milestone Pharmaceuticals Main Business
5.5.3 Milestone Pharmaceuticals Angina Products, Services and Solutions
5.5.4 Milestone Pharmaceuticals Angina Revenue (US$ Million) & (2018-2023)
5.5.5 Milestone Pharmaceuticals Recent Developments
5.6 Juventas Therapeutics
5.6.1 Juventas Therapeutics Profile
5.6.2 Juventas Therapeutics Main Business
5.6.3 Juventas Therapeutics Angina Products, Services and Solutions
5.6.4 Juventas Therapeutics Angina Revenue (US$ Million) & (2018-2023)
5.6.5 Juventas Therapeutics Recent Developments
5.7 ViroMed
5.7.1 ViroMed Profile
5.7.2 ViroMed Main Business
5.7.3 ViroMed Angina Products, Services and Solutions
5.7.4 ViroMed Angina Revenue (US$ Million) & (2018-2023)
5.7.5 ViroMed Recent Developments
5.8 Kuhnil Pharmaceutical
5.8.1 Kuhnil Pharmaceutical Profile
5.8.2 Kuhnil Pharmaceutical Main Business
5.8.3 Kuhnil Pharmaceutical Angina Products, Services and Solutions
5.8.4 Kuhnil Pharmaceutical Angina Revenue (US$ Million) & (2018-2023)
5.8.5 Kuhnil Pharmaceutical Recent Developments
6 North America
6.1 North America Angina Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Angina Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Angina Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Angina Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Angina Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Angina Market Dynamics
11.1 Angina Industry Trends
11.2 Angina Market Drivers
11.3 Angina Market Challenges
11.4 Angina Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
